Stock VDRM VIADERMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News ViaDerma, Inc.

Equities

VDRM

US92555K1016

Delayed OTC Markets
Other stock markets
 10:11:21 31/05/2024 pm IST 		5-day change 1st Jan Change
0.0067 USD -0.74% Intraday chart for ViaDerma, Inc. -2.90% -36.79%
2023 ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product CI
2023 ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
AQ
CapitalGainsReport: Top Stocks Under Two Cents To Radar Today (ATVK, VDRM, RNVA, ELTP)
AQ
BigTime Penny Stocks: Potential Break-Out Stocks to Watch (DPUI, RCIT, VDRM)
AQ
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
AQ
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More 
AQ
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
AQ
ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
CI
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
AQ
ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product
CI
ViaDerma Provides an Update on Current & Future Business Activities
AQ
ViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth Online
AQ
ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
AQ
ViaDerma Successfully Completes Quality Control Testing of its New Vitastem Products
AQ
ViaDerma, Inc. Successfully Completes Quality Control Testing of Its New Vitastem Products
CI
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
AQ
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
AQ
ViaDerma : Annual Report
PU
ViaDerma : Attorney Letter with Respect to Current Information
PU
ViaDerma : Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
AQ
ViaDerma, Inc. Set to Launch Two New and Improved Versions of Its Flagship Product, Vitastem and Vitastem Ultra
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VDRM Stock
  4. News ViaDerma, Inc.